Tag Archives: GLP1

Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes  investor.lilly.comView Full Coverage on Google News Source link

GLP-1 craze fuels rise of protein snacks with new Protein Pop-Tarts, Doritos coming  Axios Pop-Tarts Is Releasing a First-Of-Its-Kind Product—and We Want Every Flavor  Allrecipes Food firms scramble to meet the high-protein craze  BBC From Doritos to Pop-Tarts, Big Food’s $67 billion obsession is protein-packed everything: ‘It’s going to keep coming’  Fortune Pop-Tarts brings back #1 fan-requested flavor, launches new protein line  FOX 8 News …

Next time you’re cruisin’ through Costco to get your $1.50 hot dog and bulk chicken thighs, if Ozempic or Wegovy are also on your list, you’re in luck. Novo Nordisk, the company that owns both Wegovy and Ozempic, will be selling the medicine at nearly half the out-of-pocket price of other pharmacies at just $499. The company’s U.S. president David …

To read more of Derek’s reporting on GLP-1 drugs, you can subscribe to his Substack here. GLP-1 drugs like Ozempic and Zepbound don’t just help with type 2 diabetes and weight loss. They seem to curb alcohol, cocaine, and tobacco use among addicts. In some studies, they prevent strokes, heart attacks, chronic kidney disease, sleep apnea, and Parkinson’s disease. They’re associated with a …

Lilly’s oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial  Eli Lilly and Company Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial  CNBC Daily weight loss pill can help cut body weight by a fifth, trial shows  The Guardian Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say  Bloomberg.com Lilly weight-loss pill could be FDA-approved by year-end  Reuters Source …

Courcoulas, A. P. et al. Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes. JAMA 331, 654–664 (2024). Article  PubMed  PubMed Central  Google Scholar  Mingrone, G. et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 386, 964–973 (2015). Article  PubMed  …

How microdosing GLP-1 drugs became a longevity ‘craze’  The Washington Post Opinion | Americans Don’t Need Ozempic to Cure Obesity  The Wall Street Journal How do weight loss jabs work? Dr Amir Khan reveals all you need to know  Woman & Home Talk to a doctor before microdosing GLP-1 drugs  UCLA Health Ozempic doesn’t work for everybody  think.kera.org Source link

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity  Eli Lilly and Company Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval  CNBC Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals  The Wall Street Journal Eli Lilly’s weight-loss pill meets …

Cassandra Smith has rheumatoid arthritis (RA) and knows all too well how debilitating the autoimmune condition can be. Her grandmother died of complications from RA, and in the last few months of her life, it was Smith who served as her caregiver, administering doses of methotrexate to treat her pain and inflammation. The drug, a form of chemotherapy also used …

GLP-1 drugs are linked to lower cancer risk: study (NVO:NYSE)  Seeking Alpha Good News on GLP-1s and Cancer Risk, With One Exception  MedPage Today Health Rounds: GLP-1 drugs linked to lower cancer risks  Reuters GLP-1s Found to Reduce Cancer Risk in People With Obesity  AJMC Weight loss jabs like Mounjaro linked to ‘silent cancer’ that is surging in under-50s, warn experts: ‘We need to …